Yao Zhang1, Ruiting Zhang1, Minming Zhang1, Yong Zhang2, and Peiyu Huang1
1The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 2GE Healthcare, Shanghai, China
Synopsis
The association between
the glymphatic dysfunction and cerebral small vessel disease (SVD) is still unclear due a lack of in vivo measures. In this
work, we employed a novel method based on the coupling between global blood-oxygen-level-dependent (gBOLD) signal and cerebrospinal fluid
(CSF) inflow, which could detect alterations in CSF dynamics. We found that patients with severe SVD had significantly impaired
glymphatic function. The dilation of peri-vascular space and the presence of diabetes were
associated with worse glymphatic function. These results may provide useful knowledge for understanding the mechanism of SVD and improving clinical treatment.
Introduction
Glymphatic
dysfunction may participate in the initiation and progression of cerebral small
vessel disease (SVD)1-3. Currently, the association between glymphatic
dysfunction and SVD has not been fully demonstrated in human due to a lack of in
vivo measures. Specifically, which vascular risk factor or brain imaging
marker was associated with impaired glymphatic function, and their causal
relationships are not clear.
Decreases in
driving forces may impair glymphatic clearance. While the effect of cardiac
pulsatility on cerebrospinal fluid (CSF) inflow has been well confirmed4, fluctuations in global cerebral blood flow (CBF) due to
low-frequency (<0.1Hz) intrinsic
vasomotor contractions or neural activities may produce much larger forces5, 6. This phenomenon could be detected in vivo by
measuring the coupling between global CBF (reflected by global
blood-oxygen-level-dependent signal, gBOLD) and CSF inflow (reflected by
inflow-related image enhancement)7. Studies confirmed that this gBOLD-CSF coupling
exists either during sleep or wakefulness6, 7. Furthermore, altered coupling was found closely
associated with pathological markers and clinical functions in patients with
Alzheimer’s disease8 and Parkinson’s disease9, suggesting its potential as a marker of
glymphatic function.
In
the present study, we aim to investigate: (1) the association between SVD
severity (including specific vascular factors) and glymphatic dysfunction
measured by gBOLD-CSF coupling; (2) the relationship between the gBOLD-CSF
coupling and cognitive impairments.Methods
The study protocols were approved by the ethics
committee of the 2nd Affiliated Hospital, Zhejiang
University School of Medicine. All
participants signed informed consent on admission.
One hundred
and forty-six SVD patients underwent a 3T MRI examination (acquiring T1-weighted (T1W) images, T2 fluid attenuated inversion recovery (T2
FLAIR) images,susceptibility-weighted (SWI) images and resting-state functional MRI
(rsfMRI) images). All participants
signed informed consent on admission. The demographic and clinical information were collected, and the subjects were required to complete a set of neuropsychological assessments covering global cognition, executive function
and short-term
memory.
We evaluated the SVD imaging markers according to the Standards for Reporting Vascular Changes on Neuroimaging
(STRIVE), including white matter hyperintensity (WMH), lacunes, microbleeds (CMBs)
and perivascular space (PVS) in the basal ganglia (BG) and centrum semiovale (CSO) regions.
Consistent
with previous studies7-9, the gBOLD signal was extracted from cortical gray matter, and CSF inflow signal was extracted frome the bottom slices of fMRI images (near
the bottom of the cerebellum), because they were most sensitive to the CSF
inflow effect7. We
manually drew the CSF ROIs on functional images, and its anatomic location was
further confirmed on T1 images which were co-registered with functional images
(Figure 1). We set the
BOLD signal as reference and calculated the maximal cross-correlation between
the gBOLD signal and CSF inflow over a range time lags (-20s ~ 20s) for each
patient. Besides this, the cross-correlation function between the negative
derivative of the global BOLD signal and CSF signal were also calculated for
demonstrating that the oscillation of cerebral blood volume would lead to the
CSF dynamics. Finally, we verified the credibility of the above
cross-correlation between BOLD and CSF signals by permutation test. To help better
understand the result, the opposite of gBOLD-CSF coupling----Couplinginv----was calculated and used in statistical
analyses. Bigger Couplinginv indicates better
glymphatic function. Head motion (reflected by framewise displacement) and arousal state (reflected by the standard deviation of the gBOLD signal were calculated and introduced as covariates.
We performed correlation analyses to explore the relationships between the confounders and Couplinginv. Multiple linear regression models were employed to investigate the associations between the Couplinginv and vascular factors, as well as cognitive scores. Result
The median age was 67 years, and 66 (45.2%) were
female. The median educational year was 8. In general, the subjects had moderate-to-severe SVD. Correlations between Couplinginv and head motion \arousal state were not significant. Couplinginv was negatively correlated with
the age (r = -0.187, p = 0.02).
Lower Couplinginv
was associated with severer SVD (β = -0.177, p = 0.037). The dPVS (β = -0.165, p = 0.042) and diabetes (β
= -0.181, p = 0.026) were associated with reduced gBOLD-CSF coupling. Stronger coupling was significantly related
to better Digit Symbol Substitution
Test performance (β = 0.147, p = 0.039). Discussion
In this study, we found that severe SVD patients
had reduced gBOLD-CSF coupling, indicating alteration in CSF dynamics supporting
the glymphatic function. This provides evidence regarding functional impairments
of the glymphatic system, in addition to PVS structural changes in SVD.
Among all
the SVD imaging markers, reduced coupling was associated with BG-PVS dilation,
suggesting coherent structural-functional changes. It might be due to that the
vacuum effect induced by vasoconstriction decreased, and directional flow
turned into turbulence in large dPVS. The diabetes could damage vascular smooth muscle cells, leading to impaired vasomotor and decreased CSF driving forces, yielding lower gBOLD-CSF coupling.
Our findings may provide useful knowledge for understanding the
mechanism of SVD and improving clinical treatment. Futures studies in larger cohorts encompassing different stages of SVD are needed to validate these results.Acknowledgements
This study was supported by the 13th
Five-year Plan for National Key Research and Development Program of China, the
National Natural Science Foundation of China, the Natural Science Foundation of
Zhejiang Province, and the China Postdoctoral Science Foundation.References
1. Zhang W, Zhou
Y, Wang J, et al. Glymphatic clearance function in patients with cerebral small
vessel disease. Neuroimage 2021;238:118257.
2. Mestre H,
Kostrikov S, Mehta RI, Nedergaard M. Perivascular spaces, glymphatic
dysfunction, and small vessel disease. Clin Sci (Lond) 2017;131:2257-2274.
3. Benveniste H,
Nedergaard M. Cerebral small vessel disease: A glymphopathy? Curr Opin
Neurobiol 2021;72:15-21.
4. Hablitz LM,
Plá V, Giannetto M, et al. Circadian control of brain glymphatic and lymphatic
fluid flow. Nat Commun 2020;11:4411.
5. Helakari H,
Korhonen V, Holst S, et al. Sleep-specific changes in physiological brain
pulsations. bioRxiv 2020:2020.2009.2003.280479.
6. Yang H-C,
Inglis B, Talavage TM, et al. Coupling between cerebrovascular oscillations and
CSF flow fluctuation during wakefulness: An fMRI study. bioRxiv 2021:2021.2003.2029.437406.
7. Fultz NE,
Bonmassar G, Setsompop K, et al. Coupled electrophysiological, hemodynamic, and
cerebrospinal fluid oscillations in human sleep. Science 2019;366:628-631.
8. Han F, Chen
J, Belkin-Rosen A, et al. Reduced coupling between cerebrospinal fluid flow and
global brain activity is linked to Alzheimer disease-related pathology. PLoS
Biol 2021;19:e3001233.
9. Han F, Brown
GL, Zhu Y, et al. Decoupling of Global Brain Activity and Cerebrospinal Fluid
Flow in Parkinson's Disease Cognitive Decline. Mov Disord 2021;36:2066-2076.